Targeting FGFR, ephrins, Mer, MET, and PDGFR-α in non-small cell lung cancer

MeSH terms

• Antineoplastic Agents / therapeutic use*
• Carcinoma, Non-Small-Cell Lung / drug therapy*
• Carcinoma, Non-Small-Cell Lung / metabolism
• Clinical Trials as Topic
• Ephrins / antagonists & inhibitors*
• Ephrins / metabolism
• Humans
• Lung Neoplasms / drug therapy*
• Lung Neoplasms / metabolism
• Proto-Oncogene Proteins / antagonists & inhibitors*
• Proto-Oncogene Proteins / metabolism
• Proto-Oncogene Proteins c-met / antagonists & inhibitors*
• Proto-Oncogene Proteins c-met / metabolism
• Receptor Protein-Tyrosine Kinases / antagonists & inhibitors*
• Receptor Protein-Tyrosine Kinases / metabolism
• Receptor, Fibroblast Growth Factor, Type 1 / antagonists & inhibitors*
• Receptor, Fibroblast Growth Factor, Type 1 / metabolism
• Receptor, Platelet-Derived Growth Factor alpha / antagonists & inhibitors*
• Receptor, Platelet-Derived Growth Factor alpha / metabolism
• c-Mer Tyrosine Kinase